AM3 administration appears to reverse the non-responder status to hepatitis B vaccination in haemodialysis (HD) patients.

被引：0
|
作者：
Jarillo, MD
GarciaMartin, F
Sada, G
Calvo, CG
Prieto, A
Goni, M
Villarubia, VG
deMon, MA
机构：
[1] UNIV ALCALA DE HENARES, IMMUNOL IF CANTABRIA, HOSP GEN GUADALAJARA, SERV NEPHROL, MADRID, SPAIN
[2] UNIV ALCALA DE HENARES, IMMUNOL IF CANTABRIA, HOSP GEN GUADALAJARA, INTERNAL MED SERV, MADRID, SPAIN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A2640 / A2640
页数：1
相关论文
共 42 条
  • [21] Interferon alpha plus ribavirin tor chronic hepatitis C genotype 1b non-responder patients to interferon alone.
    Iacono, OL
    Castro, A
    Diago, M
    Cors, R
    Borque, MJ
    Buey, LG
    Monzon, CG
    Pedreira, J
    Otero, RM
    HEPATOLOGY, 1999, 30 (04) : 266A - 266A
  • [22] Pegylated interferon alpha2b plus ribavirin in non responder and naive chronic hepatitis C patients.
    Ripault, MP
    Martinot, M
    Boyer, N
    Giuily, N
    Castelnau, C
    Pouteau, M
    Tarik, A
    Marcellin, P
    HEPATOLOGY, 2002, 36 (04) : 596A - 596A
  • [23] Long-term administration of interferon-α in non-responder patients with chronic hepatitis C:: follow-up of liver fibrosis over 5 years
    Guerret, S
    Desmoulière, A
    Chossegros, P
    Costa, AMA
    Badid, C
    Trépo, C
    Grimaud, JA
    Chevallier, M
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 (02) : 125 - 133
  • [24] Retreatment for chronic hepatitis C of interferon non-responder patients.: Preliminary results of a multicenter randomized controlled trial of interferon plus ribavirin versus interferon alone.
    de Lédinghen, V
    Bernard, PH
    Trimoulet, P
    Bourlière, M
    Portal, I
    Rémy, AJ
    Szostak, N
    Longo, F
    Thiefin, G
    Abergel, A
    Dumas, F
    Lucidarme, D
    Blanc, P
    Zylberberg, H
    Capron, D
    Doll, J
    Fleury, H
    Couzigou, P
    HEPATOLOGY, 1998, 28 (04) : 374A - 374A
  • [25] The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid
    Ocak, Sabahattin
    Eskiocak, Ali Fuat
    NEPHROLOGY, 2008, 13 (06) : 487 - 491
  • [26] PhII proof of concept study of celgosivir in combination with peginterferon α-2b and ribavirin in chronic hepatitis C genotype-1 non-responder patients
    Kaita, K.
    Yoshida, E.
    Kunimoto, D.
    Anderson, F.
    Morris, S.
    Marotta, P.
    Scully, L.
    Peltekian, K.
    Enns, R.
    Diaz-Mitoma, F.
    Lee, S.
    Worobetz, L.
    Pankovich, J.
    Petersen, A. K.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S56 - S57
  • [27] Phase II study of celgosivir in combination with peginterferon alfa-2b and ribavirin in chronic hepatitis C genotype-1 non-responder patients
    Kaita, Kelly D.
    Yoshida, Eric M.
    Kunimoto, Dennis
    Anderson, Frank
    Sherman, Morris
    Marotta, Paul
    Scully, Linda J.
    Peltekian, Kevork M.
    Enns, Robert A.
    Diaz-Mitoma, Francisco
    Lee, Sam S.
    Worobetz, Lawrence
    Pankovich, Jim
    Petersen, Annkatrin
    GASTROENTEROLOGY, 2007, 132 (04) : A740 - A740
  • [28] Which is the most cost-effective combination therapy using interferon alfa-2b plus ribavirin for non-responder patients with chronic hepatitis C?.
    Ricardo, MO
    Carmen, A
    Angel, CM
    Leslie, F
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [29] Evaluation of initial biochemical and virological responses to induction therapy with interferon-A2B in combination with ribavirin and ketoprofen for non-responder patients with chronic hepatitis C.
    Munoz, AE
    Levi, D
    Miguez, C
    Cisterna, D
    Terg, R
    HEPATOLOGY, 2000, 32 (04) : 554A - 554A
  • [30] Efficacy of interferon-alpha 2b in combination with ribavirin in the treatment of non-responder patients with chronic hepatitis C: A randomised-controlled trial.
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Paraskevas, E
    Avgerinos, A
    Kanatakis, S
    Vaffiadis, I
    Delladetsima, J
    Demonakou, M
    Sypsa, V
    Hatzakis, A
    HEPATOLOGY, 1999, 30 (04) : 632A - 632A
12345